Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease
2011

Genome-wide copy number variation in autoimmune Addison's disease

Sample size: 352 publication Evidence: moderate

Author Information

Author(s): Brønstad Ingeborg, Wolff Anette SB, Løvås Kristian, Knappskog Per M, Husebye Eystein S

Primary Institution: Institute of Medicine, University of Bergen

Hypothesis

Can copy number variation (CNV) contribute to genetic susceptibility in autoimmune Addison's disease?

Conclusion

The study identified two novel CNV associations with Addison's disease, specifically UGT2B28 and ADAM3A.

Supporting Evidence

  • Low copy number of UGT2B28 was significantly more frequent in AD patients compared to controls.
  • High copy number of ADAM3A was associated with Addison's disease.
  • The study involved a total of 352 patients with autoimmune Addison's disease.

Takeaway

Researchers looked at the genes of people with Addison's disease and found some that are more common in them than in healthy people, which might help explain why they get sick.

Methodology

A genome-wide study using the Affymetrix GeneChip® Genome-Wide Human SNP Array 6.0 was conducted in patients with autoimmune Addison's disease, followed by duplex Taqman real-time PCR assays for further investigation.

Limitations

The study may not account for all genetic and environmental factors influencing Addison's disease.

Participant Demographics

63% females, 37% males; mean age 57 years, range 13 - 93 years.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2350-12-111

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication